KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Other Non-Current Assets: 2020-2025

Historic Other Non-Current Assets for AbCellera Biologics (ABCL) over the last 5 years, with Sep 2025 value amounting to $53.1 million.

  • AbCellera Biologics' Other Non-Current Assets fell 60.46% to $53.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.1 million, marking a year-over-year decrease of 60.46%. This contributed to the annual value of $96.5 million for FY2024, which is 2.43% up from last year.
  • As of Q3 2025, AbCellera Biologics' Other Non-Current Assets stood at $53.1 million, which was down 7.64% from $57.5 million recorded in Q2 2025.
  • AbCellera Biologics' 5-year Other Non-Current Assets high stood at $134.2 million for Q3 2024, and its period low was $9.5 million during Q1 2021.
  • Moreover, its 3-year median value for Other Non-Current Assets was $94.2 million (2023), whereas its average is $90.8 million.
  • As far as peak fluctuations go, AbCellera Biologics' Other Non-Current Assets skyrocketed by 354.43% in 2022, and later plummeted by 60.46% in 2025.
  • AbCellera Biologics' Other Non-Current Assets (Quarterly) stood at $30.6 million in 2021, then surged by 51.20% to $46.3 million in 2022, then soared by 103.41% to $94.2 million in 2023, then increased by 2.43% to $96.5 million in 2024, then crashed by 60.46% to $53.1 million in 2025.
  • Its Other Non-Current Assets was $53.1 million in Q3 2025, compared to $57.5 million in Q2 2025 and $61.6 million in Q1 2025.